{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:52:54Z","timestamp":1791438774588,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["3115\/19"],"award-info":[{"award-number":["3115\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["139\/23"],"award-info":[{"award-number":["139\/23"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["2031\/19"],"award-info":[{"award-number":["2031\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102941","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:12:28Z","timestamp":1777306348000},"page":"102941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCs"],"prefix":"10.1016","volume":"37","author":[{"given":"Orli","family":"Knop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimrod","family":"Ben Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nechama","family":"Kalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dor","family":"Breier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Baider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Nee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etai","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Somekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raz","family":"Somech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3388-6202","authenticated-orcid":false,"given":"Ayal","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102941_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.iac.2015.07.002","article-title":"Severe Combined Immunodeficiency Disorders","volume":"35","author":"Chinn","year":"2015","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.omtn.2026.102941_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.semperi.2015.03.004","article-title":"History and current status of newborn screening for severe combined immunodeficiency","volume":"39","author":"Kwan","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.omtn.2026.102941_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The gamma(c) Family of Cytokines: Basic Biology to Therapeutic Ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102941_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/clim.2000.4846","article-title":"Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency","volume":"95","author":"Niemela","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.omtn.2026.102941_bib5","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.jaip.2022.04.013","article-title":"Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel","volume":"10","author":"Lev","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.omtn.2026.102941_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.omtn.2026.102941_bib7","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2015.04.027","article-title":"Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?","volume":"136","author":"Cowan","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.omtn.2026.102941_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","article-title":"Treating Immunodeficiency through HSC Gene Therapy","volume":"22","author":"Booth","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2026.102941_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/hum.2015.047","article-title":"Clinical applications of gene therapy for primary immunodeficiencies","volume":"26","author":"Cicalese","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102941_bib10","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102941_bib11","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102941_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ymthe.2018.01.012","article-title":"Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors","volume":"26","author":"Holstein","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102941_bib13","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/sj.mt.6300297","article-title":"New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy","volume":"15","author":"Pike-Overzet","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102941_bib14","series-title":"Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders","author":"Brunetti-Pierri","year":"2017"},{"key":"10.1016\/j.omtn.2026.102941_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrg2985","article-title":"Ex vivo gene transfer and correction for cell-based therapies","volume":"12","author":"Naldini","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102941_bib16","article-title":"Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells","volume":"2","author":"Allen","year":"2020","journal-title":"Front Genome"},{"key":"10.1016\/j.omtn.2026.102941_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/hum.2016.107","article-title":"Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles","volume":"27","author":"Yu","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102941_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtn.2022.12.006","article-title":"Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs","volume":"31","author":"Iancu","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102941_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/crispr.2021.0128","article-title":"High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells","volume":"5","author":"Allen","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.omtn.2026.102941_bib20","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1038\/s41467-019-13620-5","article-title":"Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102941_bib21","article-title":"CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells","volume":"13","author":"Brault","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102941_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102941_bib23","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1038\/s41467-023-42036-5","article-title":"CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications","volume":"14","author":"Allen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102941_bib24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102941_bib25","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1074\/jbc.270.12.6523","article-title":"The conserved box 1 motif of cytokine receptors is required for association with JAK kinases","volume":"270","author":"Tanner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2026.102941_bib26","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1182\/blood.V88.5.1708.1708","article-title":"T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient","volume":"88","author":"Morelon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib27","article-title":"One Year Follow-up on the First Patient Treated with Nula-Cel: An Autologous CRISPR\/Cas9 Gene Corrected CD34+ Cell Product to Treat Sickle Cell Disease","volume":"142","author":"David","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660302","article-title":"Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for Ex-Vivo Gene Editing","volume":"12","author":"Dudek","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102941_bib29","article-title":"CRISPR nuclease off-target activity and mitigation strategies","volume":"4","author":"Wienert","year":"2022","journal-title":"Front Genome"},{"key":"10.1016\/j.omtn.2026.102941_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.omtm.2020.04.027","article-title":"Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System","volume":"17","author":"Shapiro","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102941_bib31","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2015-11-683235","article-title":"Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome","volume":"127","author":"Hubbard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib32","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood.V94.9.3027","article-title":"Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach","volume":"94","author":"Lo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.0903528","article-title":"Implications for gene therapy-limiting expression of IL-2R gamma c delineate differences in signaling thresholds required for lymphocyte development and maintenance","volume":"185","author":"Orr","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102941_bib34","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V95.10.3071","article-title":"Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer","volume":"95","author":"Soudais","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib35","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/JVI.01990-14","article-title":"Insight into the mechanism of inhibition of adeno-associated virus by the Mre11\/Rad50\/Nbs1 complex","volume":"89","author":"Lentz","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102941_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh8162","article-title":"Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency","volume":"16","author":"Castiello","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102941_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.4021","article-title":"Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency","volume":"36","author":"Canny","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102941_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051329","article-title":"Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders","volume":"15","author":"Allen","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2026.102941_bib40","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1038\/s41467-023-40344-4","article-title":"Simultaneous inhibition of DNA-PK and Pol\u03f4 improves integration efficiency and precision of genome editing","volume":"14","author":"Wimberger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102941_bib41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2026.102941_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4939-1862-1_14","article-title":"Gene editing using ssODNs with engineered endonucleases","volume":"1239","author":"Chen","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102941_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41587-022-01418-8","article-title":"High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails","volume":"41","author":"Shy","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102941_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102941_bib45","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","article-title":"CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity","volume":"38","author":"Lazzarotto","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102941_bib46","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41467-023-38448-y","article-title":"Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy","volume":"14","author":"Scala","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102941_bib47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.102941_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102941_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1472-6750-11-80","article-title":"RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers","volume":"11","author":"Dobosy","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.omtn.2026.102941_bib50","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41467-021-22417-4","article-title":"CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data","volume":"12","author":"Amit","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:11:06Z","timestamp":1791436266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126001125"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102941","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102941"}}